Association Between Microscopic Colitis and Parkinson's Disease in a Swedish Population.
Parkinson's disease
cohort study
microscopic colitis
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
04
02
2021
received:
26
10
2020
accepted:
08
03
2021
pubmed:
26
3
2021
medline:
1
9
2021
entrez:
25
3
2021
Statut:
ppublish
Résumé
Gastrointestinal inflammation has been linked with Parkinson's disease (PD). Microscopic colitis (MC) is an intestinal inflammatory disease with unknown relationship with PD. This study aimed to examine the association of MC with PD risk. In this nationwide matched cohort study in Sweden, PD incidence was compared between 12,609 patients with histologically confirmed MC and a matched population cohort of 58,879 MC-free individuals and a sibling cohort comprising all unaffected siblings of the MC patients (N During a mean follow-up of ~7 years, we identified 449 incident PD diagnoses among the MC patients and the population cohort. Overall, MC was associated with an adjusted HR of 1.76 for PD, but the association attenuated substantially during follow-up. In the time-varying effects model, PD hazard was 3.45-fold (95% CI: 2.42, 4.93) higher during the first 2 years after biopsy and 1.80-fold (95% CI: 1.23, 2.64) higher during the following 3 years among MC versus MC-free individuals but was not different beyond 5 years after biopsy (HR: 1.03; 95% CI: 0.68, 1.54). This temporal pattern of MC-PD associations persisted when comparing MC patients to their siblings. In a post hoc case-control analysis, we also detected a strong association between MC and preexisting PD (odds ratio: 3.46; 95% CI: 2.91, 4.12). Our findings suggest that MC may not be a risk factor for PD; instead, it may co-occur with PD as a comorbidity or develop after a diagnosis of PD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Sections du résumé
BACKGROUND
Gastrointestinal inflammation has been linked with Parkinson's disease (PD). Microscopic colitis (MC) is an intestinal inflammatory disease with unknown relationship with PD.
OBJECTIVE
This study aimed to examine the association of MC with PD risk.
METHODS
In this nationwide matched cohort study in Sweden, PD incidence was compared between 12,609 patients with histologically confirmed MC and a matched population cohort of 58,879 MC-free individuals and a sibling cohort comprising all unaffected siblings of the MC patients (N
RESULTS
During a mean follow-up of ~7 years, we identified 449 incident PD diagnoses among the MC patients and the population cohort. Overall, MC was associated with an adjusted HR of 1.76 for PD, but the association attenuated substantially during follow-up. In the time-varying effects model, PD hazard was 3.45-fold (95% CI: 2.42, 4.93) higher during the first 2 years after biopsy and 1.80-fold (95% CI: 1.23, 2.64) higher during the following 3 years among MC versus MC-free individuals but was not different beyond 5 years after biopsy (HR: 1.03; 95% CI: 0.68, 1.54). This temporal pattern of MC-PD associations persisted when comparing MC patients to their siblings. In a post hoc case-control analysis, we also detected a strong association between MC and preexisting PD (odds ratio: 3.46; 95% CI: 2.91, 4.12).
CONCLUSIONS
Our findings suggest that MC may not be a risk factor for PD; instead, it may co-occur with PD as a comorbidity or develop after a diagnosis of PD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1919-1926Subventions
Organisme : Medical Research Council
ID : MC_UU_00019/2
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Références
Collaborators GPsD. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2018;17(11):939-953.
Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011;26(suppl 1):S1-S58.
Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers 2017;3:17013.
Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003;110(5):517-536.
Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 2014;128(6):805-820.
Masuda-Suzukake M, Nonaka T, Hosokawa M, et al. Prion-like spreading of pathological α-synuclein in brain. Brain 2013;136(Pt 4):1128-1138.
Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA. α-Synuclein in gut endocrine cells and its implications for Parkinson's disease. JCI Insight 2017;2(12):e92295.
Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease. Brain 2019;142(6):1690-1700.
Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis 2017;3:3.
Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 2018;45:53-61.
Chen QQ, Haikal C, Li W, Li JY. Gut inflammation in association with pathogenesis of Parkinson's disease. Front Mol Neurosci 2019;12:218.
Münch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European microscopic colitis group. J Crohns Colitis 2012;6(9):932-945.
Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Münch A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol 2019;4(4):305-314.
Khalili H, Burke KE, Roelstraete B, Sachs MC, Olén O, Ludvigsson JF. Microscopic colitis and risk of inflammatory bowel disease in a Nationwide cohort study. Gastroenterology 2020;158(6):1574-1583.e1572.
Green HD, Beaumont RN, Thomas A, et al. Genome-wide association study of microscopic colitis in the UKbiobank confirms immune-related pathogenesis. J Crohns Colitis 2019;13(12):1578-1582.
Wan QY, Zhao R, Wu XT. Older patients with IBD might have higher risk of Parkinson's disease. Gut 2020;69(1):193-194.
Witoelar A, Jansen IE, Wang Y, et al. Genome-wide Pleiotropy between Parkinson disease and autoimmune diseases. JAMA Neurol 2017;74(7):780-792.
Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015;30(3):350-358.
van IJzendoorn SCD, Derkinderen P. The intestinal barrier in Parkinson's disease: current state of knowledge. J Parkinsons Dis 2019;9(s2):S323-S329.
Morgan DM, Cao Y, Miller K, et al. Microscopic colitis is characterized by intestinal dysbiosis. Clin Gastroenterol Hepatol 2020;18(4):984-986.
van Hemert S, Skonieczna-Żydecka K, Loniewski I, Szredzki P, Marlicz W. Microscopic colitis-microbiome, barrier function and associated diseases. Ann Transl Med 2018;6(3):39.
Carrasco A, Esteve M, Salas A, et al. Immunological differences between lymphocytic and collagenous colitis. J Crohns Colitis 2016;10(9):1055-1066.
Ludvigsson JF, Lashkariani M. Cohort profile: ESPRESSO (epidemiology strengthened by histoPathology reports in Sweden). Clin Epidemiol 2019;11:101-114.
Bergman D, Clements MS, Khalili H, Agréus L, Hultcrantz R, Ludvigsson JF. A nationwide cohort study of the incidence of microscopic colitis in Sweden. Aliment Pharmacol Ther 2019;49(11):1395-1400.
Svensson M, Bergman D, Olén O, et al. Validating microscopic colitis (MC) in Swedish pathology registers. Scand J Gastroenterol 2018;53(12):1469-1475.
Inzelberg R, Schecthman E, Paleacu D, et al. Onset and progression of disease in familial and sporadic Parkinson's disease. Am J Med Genet A 2004;124A(3):255-258.
Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16(7):726-735.
Chande N. Microscopic colitis: an approach to treatment. Can J Gastroenterol 2008;22(8):686-688.
Ludvigsson JF, Almqvist C, Bonamy AK, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol 2016;31(2):125-136.
Ekbom A. The Swedish multi-generation register. Methods Mol Biol 2011;675:215-220.
Frisell T, Öberg S, Kuja-Halkola R, Sjölander A. Sibling comparison designs: bias from non-shared confounders and measurement error. Epidemiology 2012;23(5):713-720.
Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
Feldman AL, Johansson AL, Gatz M, et al. Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers. Neuroepidemiology 2012;38(3):186-193.
Ludvigsson JF, Svedberg P, Olén O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol 2019;34(4):423-437.
Zhu F, Li C, Gong J, Zhu W, Gu L, Li N. The risk of Parkinson's disease in inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis 2019;51(1):38-42.
Shah A, Walker M, Burger D, et al. Link between celiac disease and inflammatory bowel disease. J Clin Gastroenterol 2019;53(7):514-522.
Gentile N, Yen EF. Prevalence, pathogenesis, diagnosis, and management of microscopic colitis. Gut Liver 2018;12(3):227-235.
Team RC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2019.
Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2015;14(6):625-639.
Nerius M, Doblhammer G, Tamgüney G. GI infections are associated with an increased risk of Parkinson's disease. Gut 2020;69(6):1154-1156.
Dardiotis E, Tsouris Z, Mentis AA, et al. H. Pylori and Parkinson's disease: meta-analyses including clinical severity. Clin Neurol Neurosurg 2018;175:16-24.
Huang HK, Wang JH, Lei WY, Chen CL, Chang CY, Liou LS. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: a population-based retrospective cohort study. Parkinsonism Relat Disord 2018;47:26-31.
Kang X, Ploner A, Ludvigsson JF, et al. Clostridium difficile infection and risk of Parkinson's disease: a Swedish population-based cohort study. Eur J Neurol 2020;27(11):2134-2141.
Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014. Gut 2019;68(1):18-24.
Weimers P, Halfvarson J, Sachs MC, et al. Inflammatory bowel disease and Parkinson's disease: a Nationwide Swedish cohort study. Inflamm Bowel Dis 2019;25(1):111-123.
Lin JC, Lin CS, Hsu CW, Lin CL, Kao CH. Association between Parkinson's disease and inflammatory bowel disease: a Nationwide Taiwanese retrospective cohort study. Inflamm Bowel Dis 2016;22(5):1049-1055.